1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-abdominal Infection: A Phase 2, Randomized Clinical Trial

BACKGROUND: Ceftolozane/tazobactam (C/T), a cephalosporin–β-lactamase inhibitor combination, is approved for treatment of complicated urinary tract infections, complicated intra-abdominal infections (cIAI), and nosocomial pneumonia in adults. Safety and efficacy of C/T in pediatric participants with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Carl-Christian A, Newland, Jason, Dementieva, Natalia, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A, Bensaci, Mekki, Popejoy, Myra W, Johnson, Matthew G, De Anda, Carisa S, Rhee, Elizabeth G, Bruno, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643866/
http://dx.doi.org/10.1093/ofid/ofab466.1347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643866/
http://dx.doi.org/10.1093/ofid/ofab466.1347

Ejemplares similares